Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Crystalline pharmaceutically acceptable salt and polymorphic form of the glutaminyl cyclase inhibitor Varoglutamstat

Crystalline pharmaceutically acceptable salt and polymorphic form of the glutaminyl cyclase inhibitor Varoglutamstat

US Patent 12312335 · Granted May 27, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors2025
Inhibitors2022
Inhibitors of glutaminyl cyclase2022
Inhibitors of glutaminyl cyclase2017
Inhibitors2017
Radiolabelled glutaminyl cyclase (QC) inhibitors and uses of same2017
Inhibitors of glutaminyl cyclase2016
Inhibitors2016
Inhibitors of glutaminyl cyclase2015
Inhibitors2015
Inhibitors of glutaminyl cyclase2015
Inhibitors of protein kinases2015